欢迎访问西亚试剂!
西亚试剂banner
西亚试剂banner
西亚试剂banner

当前位置:首页 > 新闻中心

西亚试剂:Genome-wide association study identifies variants at CSF1,

发布时间:2025-07-11

Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone
Omar M E Albagha, Micaela R Visconti, Nerea Alonso, Anne L Langston, Tim Cundy, Rosemary Dargie, Malcolm G Dunlop, William D Fraser, Michael J Hooper, Gianluca Isaia, Geoff C Nicholson, Javier del Pino Montez, Rogelio Gonzalez-Sarmiento, Marco di Stefano, Albert Tenesa, John P Walsh & Stuart H Ralston

Paget's disease of bone (PDB) is a common disorder with a strong genetic component characterized by focal increases in bone turnover, which in some cases is caused by mutations in SQSTM1. To identify additional susceptibility genes, we performed a genome-wide association study in 750 individuals with PDB (cases) without SQSTM1 mutations and 1,002 controls and identified three candidate disease loci, which were then replicated in an independent set of 500 cases and 535 controls. The strongest signal was with rs484959 on 1p13 near the CSF1 gene (P = 5.38 × 10?24). Significant associations were also observed with rs1561570 on 10p13 within the OPTN gene (P = 6.09 × 10?13) and with rs3018362 on 18q21 near the TNFRSF11A gene (P = 5.27 × 10?13). These studies provide new insights into the pathogenesis of PDB and identify OPTN, CSF1 and TNFRSF11A as candidate genes for disease susceptibility.

上一篇:西亚试剂:二氯苯磺胺
下一篇:首个能在临床中改善疾病预后的处方数字疗法
版权所有:山东西亚化学有限公司

鲁ICP备20015914号-4